Becton, Dickinson and Company Follow / Connect - Business Profile & Social Media Wall / Press Room - Research

Becton, Dickinson and Company Company Profile & Social Media Wall Press Room - Press Releases

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

	Company Name:	Becton, Dickinson and Company
	Trading Symbol(s):	[NYSE: BDX]
	Contact:	Corporate Communications - BD.com
	Address:	Confidential
	City:	Franklin Lakes
	Zip code:	07417
	STATE / Prov.:	NJ
	Country:	United States
	Primary Industry:	Research
	PR Agency:	No

Your Company Advertising Here!
Showing along with this industry
- Learn more...

Latest Articles:
BD Utilizes AT&T Connectivity to Offer Connected Wireless Health Devices - [ Research ]
Alaris® System Named 2015 Best in KLAS for Smart Pumps - [ Research ]
BD Receives FDA 510(k) Clearance for New Blood Collection Device to Help Enhance Patient and Clinician ExperienceFOR LATER USE - [ Research ]
BD Unveils New Next Generation Sequencing Library Prep System at the 2016 Advances in Genome Biology and Technology Meeting - [ Research ]
BD Receives FDA 510(k) Clearance for Diagnostic Device for HIV/AIDS - [ Research ]
BD Launches BD FACSymphony™ High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types - [ Research ]
BD Licenses Technology to Advance Testing for Preeclampsia, Gestational Diabetes - [ Research ]
Fresenius Kabi USA Acquires U.S. Pharmaceutical Plant and Ready-to-Administer Drugs from BD - [ Research ]
BD Introduces Simplified Comprehensive IV Management - [ Research ]
BD Named Global Company of the Year for Clinical and Research Flow Cytometry by Frost & Sullivan - [ Pharma / BioTech / Nutrition ]
Teva Pharmaceuticals Confirms the BD PhaSeal™ System is Compatible with Chemotherapy Drug Treanda® Injection - [ Research ]
BD MAX™ Enteric Parasite Panel Receives FDA Clearance for Detection of Common and Pathogenic Intestinal Parasites - [ Research ]
BD Named 2015 Outstanding Corporate Innovator (OCI) Winner by Product Development and Management Association (PDMA) - [ Research ]
BD to Acquire Cellular Research to Develop a Leading Genomics Platform for Single Cell Analysis - [ Research ]
BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart™ Technology Designed to Improve Insulin Pump Therapy - [ Research ]
BD Participates in White House Forum on Antibiotic Stewardship - [ Research ]
BD Receives FDA Clearance for a Novel Infusion Set with BD FlowSmart™ Technology to Enhance the Use of Insulin Pumps - [ Research ]
Becton Dickinson Completes Acquisition of CareFusion - [ Research ]
European Commission Clears BD Acquisition of CareFusion - [ Pharma / BioTech / Nutrition ]
BD Acquires CRISI Medical Systems - [ Research ]
The BD™ Intelliport® Medication Management System Receives Clearance from the Food and Drug Administration (FDA) - [ Research ]
BD Receives Environmental Protection Agency (EPA) Green Power Leadership Award - [ Research ]
Becton Dickinson and CareFusion Announce Expiration of HSR Act Waiting Period in Proposed Transaction - [ Research ]
BD Acquires GenCell Biosystems - [ Research ]
BD to Acquire CareFusion for .2 Billion - [ Research ]

« Previous Page

Next Page »

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business

ó See your Ad Here! ó

PREMIUM Members

ó See your Logo Here! ó